| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Chief Commercial Officer | Stock Option (Right to Buy) | 147,000 | 20 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVDL | AVADEL PHARMACEUTICALS PLC | 20 Feb 2024 | 1 | $0 | 4 | Chief Commercial Officer | 04 Mar 2024, 06:28 |
| AVDL | AVADEL PHARMACEUTICALS PLC | 05 Jun 2023 | 1 | $0 | 4 | Chief Commercial Officer | 05 Jun 2023, 21:30 |
| AVDL | AVADEL PHARMACEUTICALS PLC | 07 Dec 2021 | 1 | $0 | 4 | Chief Commercial Officer | 09 Dec 2021, 17:44 |